Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)

NCT02141477 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual-2 patients were registered Phase I and none in Phase II

Conditions

Leukemia

Interventions

DRUG: Omacetaxine
DRUG: Decitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]